(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Justin Gover, CEO of GW Pharmaceuticals, on the drug pipeline for the UK- based company which has been developing drug treatments derived from cannabis for decades.
Bloomberg Intelligence
3,286 clip(s)
Intel Shares Fall on Report Nvidia Halts Production Test
Novo Nordisk Gets US Approval for Wegovy Obesity Pill
Larry Ellison’s Guarantee Ups Warner Bros. Stakes to a New Level